316 related articles for article (PubMed ID: 25123811)
1. Antifungal prophylaxis in lung transplantation.
Neoh CF; Snell G; Levvey B; Morrissey CO; Stewart K; Kong DC
Int J Antimicrob Agents; 2014 Sep; 44(3):194-202. PubMed ID: 25123811
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
Salavert M
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
[TBL] [Abstract][Full Text] [Related]
3. Antifungal prophylaxis in lung transplantation.
Avery RK
Semin Respir Crit Care Med; 2011 Dec; 32(6):717-26. PubMed ID: 22167399
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic antifungal agents used after lung transplantation.
Marino E; Gallagher JC
Ann Pharmacother; 2010 Mar; 44(3):546-56. PubMed ID: 20179260
[TBL] [Abstract][Full Text] [Related]
5. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
Borro JM; Solé A; de la Torre M; Pastor A; Fernandez R; Saura A; Delgado M; Monte E; Gonzalez D
Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
[TBL] [Abstract][Full Text] [Related]
6. Invasive fungal infections in liver transplantation.
Liu X; Ling Z; Li L; Ruan B
Int J Infect Dis; 2011 May; 15(5):e298-304. PubMed ID: 21345708
[TBL] [Abstract][Full Text] [Related]
7. Antifungal prophylaxis in solid organ transplant recipients.
Brizendine KD; Vishin S; Baddley JW
Expert Rev Anti Infect Ther; 2011 May; 9(5):571-81. PubMed ID: 21609268
[TBL] [Abstract][Full Text] [Related]
8. Is universal antifungal prophylaxis mandatory in lung transplant patients?
Schaenman JM
Curr Opin Infect Dis; 2013 Aug; 26(4):317-25. PubMed ID: 23743815
[TBL] [Abstract][Full Text] [Related]
9. Antifungal Prophylaxis in Lung Transplant Recipients.
Patel TS; Eschenauer GA; Stuckey LJ; Carver PL
Transplantation; 2016 Sep; 100(9):1815-26. PubMed ID: 26950711
[TBL] [Abstract][Full Text] [Related]
10. Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects.
Akan H; Antia VP; Kouba M; Sinkó J; Tănase AD; Vrhovac R; Herbrecht R
J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii5-16. PubMed ID: 24155144
[TBL] [Abstract][Full Text] [Related]
11. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
Maertens J
Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation.
Camps IR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S119-23. PubMed ID: 19013335
[TBL] [Abstract][Full Text] [Related]
13. A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis.
Koo S; Kubiak DW; Issa NC; Dietzek A; Boukedes S; Camp PC; Goldberg HJ; Baden LR; Fuhlbrigge AL; Marty FM
Transplantation; 2012 Aug; 94(3):281-6. PubMed ID: 22790447
[TBL] [Abstract][Full Text] [Related]
14. Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.
McCoy D; Depestel DD; Carver PL
Pharmacotherapy; 2009 Nov; 29(11):1306-25. PubMed ID: 19857148
[TBL] [Abstract][Full Text] [Related]
15. Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center.
Pinney MF; Rosenberg AF; Hampp C; Schain D; Akindipe O; Baz M
Pharmacotherapy; 2011 Jun; 31(6):537-45. PubMed ID: 21923437
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of invasive fungal infections in neonates and children.
Steinbach WJ
Clin Microbiol Infect; 2010 Sep; 16(9):1321-7. PubMed ID: 20840541
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens.
Corzo-León DE; Satlin MJ; Soave R; Shore TB; Schuetz AN; Jacobs SE; Walsh TJ
Mycoses; 2015 Jun; 58(6):325-36. PubMed ID: 25808822
[TBL] [Abstract][Full Text] [Related]
18. Antifungal prophylaxis in lung transplant recipients: A systematic review and meta-analysis.
Pennington KM; Baqir M; Erwin PJ; Razonable RR; Murad MH; Kennedy CC
Transpl Infect Dis; 2020 Aug; 22(4):e13333. PubMed ID: 32449237
[TBL] [Abstract][Full Text] [Related]
19. Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.
Yunus S; Pieper S; Kolve H; Goletz G; Jürgens H; Groll AH
J Antimicrob Chemother; 2014 Mar; 69(3):815-20. PubMed ID: 24198097
[TBL] [Abstract][Full Text] [Related]
20. Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey.
He SY; Makhzoumi ZH; Singer JP; Chin-Hong PV; Arron ST
Transpl Infect Dis; 2015 Feb; 17(1):14-20. PubMed ID: 25620387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]